Back to search

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics Register

Data up to Jan 2025

Published2007
Citations542
References38

Total Citations Per Year

Abstract

References (38)

Inflammation, Atherosclerosis, and Coronary Artery Disease

2005 • 8,367 citations

Inflammation in atherosclerosis

2002 • 7,873 citations

Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1995 • 5,929 citations

Inflammation in Atherosclerosis

2012 • 3,528 citations

Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

1990 • 2,566 citations

Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial

1999 • 2,358 citations

Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction

2000 • 2,092 citations

Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

2003 • 1,750 citations

Development and validation of the european league against rheumatism response criteria for rheumatoid arthritis: Comparison with the preliminary american college of rheumatology and the world health organization/international league against rheumatism criteria

1996 • 1,548 citations

Randomized, Double-Blind, Placebo-Controlled, Pilot Trial of Infliximab, a Chimeric Monoclonal Antibody to Tumor Necrosis Factor-α, in Patients With Moderate-to-Severe Heart Failure

2003 • 1,504 citations

Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations

1999 • 1,457 citations

Etanercept Therapy in Rheumatoid Arthritis

1999 • 1,407 citations

International statistical classification of diseases and related health problems. Tenth revision.

1988 • 1,382 citations

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

2001 • 1,296 citations

Cardiovascular Morbidity and Mortality in Women Diagnosed With Rheumatoid Arthritis

2003 • 1,223 citations

Deprivation

1987 • 1,060 citations

High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors

2001 • 1,040 citations

Cardiovascular death in rheumatoid arthritis: A population‐based study

2005 • 935 citations

Explaining How “High-Grade” Systemic Inflammation Accelerates Vascular Risk in Rheumatoid Arthritis

2003 • 922 citations

Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population‐based cohort study

2005 • 914 citations

Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure

2000 • 778 citations

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis.

2005 • 532 citations

STANFORD HEALTH ASSESSMENT QUESTIONNAIRE MODIFIED TO ASSESS DISABILITY IN BRITISH PATIENTS WITH RHEUMATOID ARTHRITIS

1986 • 487 citations

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction

2000 • 423 citations

Mortality in early inflammatory polyarthritis: Cardiovascular mortality is increased in seropositive patients

2002 • 368 citations

Update on the British Society for Rheumatology guidelines for prescribing TNF blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)

2005 • 340 citations

Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well.

1998 • 327 citations

Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis.

2003 • 300 citations

Stress-Activated Cytokines and The Heart: From Adaptation to Maladaptation

2003 • 291 citations

All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database.

2003 • 288 citations

Baseline levels of c‐reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten‐year followup study of a primary care–based inception cohort

2005 • 283 citations

British Society for Rheumatology Biologics Register

2003 • 239 citations

Cytokines and hemostasis.

2000 • 227 citations

The transfer of a laboratory based hypothesis to a clinically useful therapy: the development of anti-TNF therapy of rheumatoid arthritis

2004 • 79 citations

Inflammation, thrombosis and acute coronary syndromes

2005 • 69 citations

The British Society for Rheumatology Biologics Register

2005 • 67 citations

Insights into the Molecular Mechanisms of Plaque Rupture and Thrombosis

2006 • 11 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...